Exabis Library
Welcome to the e-CCO Library!
P797: Crohn’s disease and ulcerative colitis was associated with different lipid profile disorders: a nationwide population-based study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P797: Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with Inflammatory Bowel Disease: Results of a multicenter survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P798: Quality of sexual life in patients with ulcerative colitis: a monocentric observational study. On behalf of IG-IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P798: The experience of inflammatory bowel disease patients with health care in Spain: Insights from the IEXPAC project
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P798: Understanding anti-TNF treatment failure: mechanisms and management of loss of response to anti-TNF therapy, three-year data from the PANTS study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P799 Use of anti-TNF agents may reduce a risk of venous thromboembolism in Korean patients with inflammatory bowel disease: A nationwide population-based study from the National Health Insurance Database
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P799: Frequency of vaccination for herpes zoster (HZ) among inflammatory bowel disease (IBD) patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P799: Infliximab and immunomodulator combination therapy in inflammatory bowel disease – no longer inseparable?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P799: Perinatal factors and development of IBD: a national case–control study with nearly 50 years of follow-up: report from the epiIIRN database
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P800: Factors related to non-adherence behaviours of patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P800: Five-year prospective follow-up of paediatric IBD patients based on HUPIR (Hungarian paediatric IBD registry)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P800: Upadacitinib is effective and safe for Crohn's Disease: prospective real-world experience
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P801 Treatment patterns of complex perianal fistula in Crohn’s disease in five European countries: the PREFACE study, a retrospective chart review
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P801: Maintenance phase effectiveness and persistence after two years in biologic-naïve ulcerative colitis patients treated with vedolizumab or anti-TNF (VEDO-IBD-study)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P801: Physicians’ knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P801: Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004–2015
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P802 Probability of vedolizumab response as defined by clinical decision support tool is associated with lower healthcare utilisation in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P802: Perforating Crohn's Disease and pancolitis as risk factors for incident cancer: a prospective multi-centre nested case–control IG-IBD study at 6 years
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM